Principal Financial Group Inc. increased its stake in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 2.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 166,997 shares of the financial services provider’s stock after buying an additional 3,809 shares during the period. Principal Financial Group Inc. owned about 0.39% of Trupanion worth $6,224,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Jones Financial Companies Lllp lifted its holdings in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 238 shares in the last quarter. Coppell Advisory Solutions LLC grew its holdings in shares of Trupanion by 58.3% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider’s stock worth $61,000 after buying an additional 460 shares in the last quarter. Swiss National Bank raised its position in shares of Trupanion by 1.1% in the fourth quarter. Swiss National Bank now owns 66,310 shares of the financial services provider’s stock valued at $3,196,000 after buying an additional 700 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Trupanion by 4.0% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,745 shares of the financial services provider’s stock valued at $904,000 after buying an additional 717 shares during the period. Finally, Quarry LP acquired a new stake in Trupanion during the fourth quarter worth approximately $39,000.
Insider Activity
In related news, CFO Fawwad Qureshi sold 2,534 shares of the stock in a transaction on Thursday, May 29th. The stock was sold at an average price of $48.31, for a total value of $122,417.54. Following the completion of the sale, the chief financial officer directly owned 3,545 shares in the company, valued at approximately $171,258.95. This represents a 41.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $45.86, for a total value of $183,440.00. Following the completion of the sale, the chief executive officer owned 118,784 shares of the company’s stock, valued at approximately $5,447,434.24. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,562 shares of company stock valued at $678,230. Company insiders own 5.42% of the company’s stock.
Trupanion Stock Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. The firm had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative net margin of 0.32% and a negative return on equity of 1.33%. Trupanion’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.16) earnings per share. As a group, research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Analyst Upgrades and Downgrades
TRUP has been the topic of several analyst reports. Piper Sandler raised their price objective on Trupanion from $52.00 to $62.00 and gave the stock an “overweight” rating in a report on Thursday, July 3rd. Lake Street Capital dropped their price objective on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $53.80.
View Our Latest Report on Trupanion
Trupanion Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- ESG Stocks, What Investors Should Know
- 3 Stocks to Cushion Your Portfolio This Earnings Season
- What is the Nasdaq? Complete Overview with History
- This Fund Manager Says You Should Get Out of Tesla and Apple—Now
- Utilities Stocks Explained – How and Why to Invest in Utilities
- JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.